Idebenone News
Idebenone currently has 3 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Idebenone with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Raxone is indicated for the treatment of visual impairment in adolescent and adult patients with Leber’s Hereditary Optic Neuropathy (LHON).
- Evidence level: L5
- Predicted indications (20):
- hepatic porphyria (99.9%)
- hepatoportal sclerosis (99.9%)
- idiopathic copper-associated cirrhosis (99.9%)
- hepatopulmonary syndrome (99.9%)
- early-onset familial noncirrhotic portal hypertension (99.9%)
- primitive portal vein thrombosis (99.9%)
- immune-mediated necrotizing myopathy (99.8%)
- osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome (99.8%)
- antisynthetase syndrome (99.8%)
- focal myositis (99.7%)
- maternally-inherited mitochondrial myopathy (99.7%)
- primary optic atrophy (99.7%)
- idiopathic eosinophilic myositis (99.7%)
- inflammatory myopathy with abundant macrophages (99.7%)
- maternally-inherited mitochondrial dystonia (99.7%)
- maternally-inherited Leigh syndrome (99.6%)
- Leber hereditary optic neuropathy (99.5%)
- juvenile nasopharyngeal angiofibroma (disease) (99.5%)
- familial nasal acilia (99.5%)
- silent sinus syndrome (99.5%)
Related News (3)
En prescrivant dès 1979 un comprimé contre l’hypertension sévère, le laboratoire Upjohn a littéralement ouvert un marché qu’aucun cardiologue n’avait imaginé
2026-10-09 hypertension
Source: Sciencepost
WHO stellt globale Roadmap gegen Bluthochdruckerkrankungen in der Schwangerschaft vor - Deutsches Ärzteblatt
2026-10-08 Bluthochdruck AF
Source: Deutsches Ärzteblatt
The generation raised on sugar rations – and what their health reveals 70 years later - The Guardian
2026-10-07 diabetes high blood pressure
Source: The Guardian
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.